Erlotinib 63304-0135
Product NDC
63304-0135- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 5, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA210300
Need to source Erlotinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erlotinib | 150 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(2)
3 BLISTER PACK in 1 CARTON (63304-135-11) / 10 TABLET, FILM COATED in 1 BLISTER PACK (63304-135-31)
30 TABLET, FILM COATED in 1 BOTTLE (63304-135-30)